A1 LONGITUDINAL CHANGES IN THE DIRECT COST OF IBD CARE IN THE BIOLOGIC ERA

BACKGROUND: While biologics are significantly costlier than other medical options for IBD, their use may lead to a diminution in downstream health care costs by decreasing the need for hospitalization and surgeries for uncontrolled symptoms or complications. Previously published work from Manitoba h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Can Assoc Gastroenterol
Main Authors: Targownik, L E, Witt, J, Bernstein, C N, Singh, H, Avina Zubieta, A, Benchimol, E I, Coward, S, Jones, J, Kaplan, G G, Murthy, S, Nguyen, G C, Pena-Sanchez, J, Shaffer, S, Tennakoon, A
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Oral Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512235/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.000
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados